Bioengineering of nano metal-organic frameworks for cancer immunotherapy
- 23 November 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nano Research
- Vol. 14 (5), 1244-1259
- https://doi.org/10.1007/s12274-020-3179-9
Abstract
Immunotherapy techniques, such as immune checkpoint inhibitors, chimeric antigen receptor (CAR) T cell therapies and cancer vaccines, have been burgeoning with great success, particularly for specific cancer types. However, side effects with fatal risks, dysfunction in tumor microenvironment and low immune response rates remain the bottlenecks in immunotherapy. Nano metal-organic frameworks (nMOFs), with an accurate structure and a narrow size distribution, are emerging as a solution to these problems. In addition to their function of temporospatial delivery, a large library of their compositions, together with flexibility in chemical interaction and inherent immune efficacy, offers opportunities for various designs of nMOFs for immunotherapy. In this review, we overview state-of-the-art research on nMOFs-based immunotherapies as well as their combination with other therapies. We demonstrate that nMOFs are predominantly customized for vaccine delivery or tumor-microenvironment modulation. Finally, a prospect of nMOFs in cancer immunotherapy will be discussed.This publication has 145 references indexed in Scilit:
- The Chemistry and Applications of Metal-Organic FrameworksScience, 2013
- Zr- and Hf-based nanoscale metal–organic frameworks as contrast agents for computed tomographyJournal of Materials Chemistry, 2012
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapyCancer and Metastasis Reviews, 2011
- Vaccine Adjuvants: Putting Innate Immunity to WorkImmunity, 2010
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trialThe Lancet, 2010
- BioMOFs: Metal–Organic Frameworks for Biological and Medical ApplicationsAngewandte Chemie, 2010
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- The safety and side effects of monoclonal antibodiesNature Reviews Drug Discovery, 2010
- Innovative strategies for co-delivering antigens and CpG oligonucleotidesAdvanced Drug Delivery Reviews, 2009
- Caspase-dependent immunogenicity of doxorubicin-induced tumor cell deathThe Journal of Experimental Medicine, 2005